BACE1 and Alzheimer disease: To test our previous hypothesis [16] that PrPC may function normally to protect against AD by reducing BACE1 activity, we have explored the relationship between PrPC level and AD pathology in two contexts: first in sporadic AD, and second in Down's syndrome.